This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your healthcare provider before using herbs, especially if you are pregnant, nursing, taking medications, or have a medical condition.
How does Pansit-Pansitan work for arthritis and inflammation?
Pansit-Pansitan (Peperomia pellucida) exerts anti-inflammatory effects through several bioactive compounds, including pellucidine, flavonoids, apiol, dillapiole, and beta-sitosterol. These compounds are believed to inhibit pro-inflammatory mediators and pathways involved in the inflammatory response. Research suggests the herb may reduce swelling and pain associated with inflammatory conditions like arthritis and gout. The evidence level for these mechanisms is rated C, indicating limited clinical trials but some pharmacological support. Traditional use and preliminary studies support its anti-inflammatory properties, though more rigorous human studies are needed.
Is Pansit-Pansitan safe to take during pregnancy?
No, Pansit-Pansitan is contraindicated during pregnancy and is considered unsafe for pregnant women. The herb contains compounds such as apiol and dillapiole, which have historically been associated with uterine stimulation and potential abortifacient effects. Women who are pregnant or attempting to conceive should avoid both internal and topical use of this herb. If you are pregnant and have used Pansit-Pansitan, consult your healthcare provider immediately. The Philippine Department of Health approval for this herb specifically excludes use during pregnancy.
What is the recommended dosage for Pansit-Pansitan?
The standard adult dosage for Pansit-Pansitan is 2-3 cups of herb tea daily when used for arthritis, gout, or anti-inflammatory purposes. To prepare, steep the fresh or dried herb in hot water for 10-15 minutes. For skin conditions, a topical poultice can be made by crushing fresh leaves and applying directly to the affected area. Dosage recommendations are based on traditional use and Philippine Department of Health guidelines (Evidence Level C). Always start with lower doses to assess tolerance, and consult a healthcare provider for personalized dosing.
Does Pansit-Pansitan interact with any medications?
Limited research exists on specific drug interactions with Pansit-Pansitan. However, due to its anti-inflammatory properties and active compounds like flavonoids and beta-sitosterol, there is potential for interaction with anticoagulant medications, antiplatelet drugs, and NSAIDs. The herb may theoretically enhance bleeding risk when combined with blood thinners. Additionally, compounds such as apiol and dillapiole may affect liver enzyme metabolism of certain drugs. Patients taking prescription medications should consult a healthcare provider before using Pansit-Pansitan. Always disclose all herbal supplements to your pharmacist and physician.
What is Pansit-Pansitan used for?
Pansit-Pansitan (Peperomia pellucida) is officially approved by the Philippine Department of Health for the treatment of arthritis, gout, and various skin conditions. Traditionally, it has been used throughout the Philippines and other tropical regions as an anti-inflammatory and analgesic remedy. The herb is applied topically for skin conditions like boils, abscesses, and wounds, while internal preparations are used for joint pain and inflammation. Evidence Level C supports these traditional uses, meaning benefits are suggested by pharmacological studies and traditional use, though more clinical trials are needed.
PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Peperomia pellucida (L.) Kunth is a tropical medicinal herb used to manage inflammatory, gastrointestinal, and respiratory disorders [PMID:35153134], exhibiting antimicrobial, antidiabetic, and antioxidant activities [PMID:30562552, PMID:39403726].
Background
Peperomia pellucida (L.) Kunth is an annual weed in the Piperaceae family, primarily distributed in the Neotropics, Africa, Southeast Asia, and Australia, typically preferring humid environments with reduced solar radiation [PMID:30562552, PMID:40630672].
Traditional uses
It is popularly employed in the treatment of abscesses, abdominal pain, skin sores, conjunctivitis, measles, kidney troubles [PMID:30562552], headache, fever, and hypertension [PMID:34759740], and is used in Cameroonian traditional medicine for fracture healing [PMID:28372562].
Active compounds
The plant contains polyphenols, tannins, flavonoids, saponins, alkaloids, and terpenoids [PMID:39403726]. Specific identified compounds include $\beta$-caryophyllene, carotol, dillapiole, ellagic acid, pellucidin A, phytol, vitexin [PMID:35153134], as well as 2,4,5-trimethoxycinnamic acid, 5,6,7-trimethoxyflavone, and sesamin [PMID:33828573].
Mechanism of action
Bioactive compounds may interact with proteins such as estrogen receptors, NOS, NF-$\kappa$B, PPAR-gamma, ACE, aldose reductase, alpha-glucosidase, alpha-amylase, DPP-IV, insulin receptor, and AChE [PMID:40630672]. In human retinal pigment epithelial cells, it suppresses glycation-induced inflammatory responses via the JAK-STAT3 signaling pathway [PMID:39037823] and modulates NF-$\kappa$B and PPAR-$\gamma$ signaling [PMID:39561439].
Clinical evidence
Evidence DHypertension
Ethyl acetate fraction of ethanolic extract showed ACE-inhibitory activity and potential hypotensive effects in hypertensive rats [PMID:34759740].
Evidence DBone Fracture Healing
Aqueous and ethanolic extracts promoted fracture healing and bone regeneration in Wistar rats [PMID:28372562, PMID:23578859].
Evidence DArthritis
Methanol extract significantly reduced inflammation diameter in complete Freund's adjuvant-induced arthritis in rats [PMID:40156794].
Evidence DCardiotoxicity
Ethanolic extract exhibited cardioprotective effects against doxorubicin-induced myocardial injury in rats [PMID:39741574].
Evidence DPeriodontitis
Extract demonstrated anti-inflammatory efficacy in rats with induced periodontitis [PMID:39539670].
Evidence DCariogenic Bacteria
Essential oils displayed antibacterial activity against Streptococcus mutans, S. mitis, S. sanguinis, S. salivarius, S. sobrinus, Enterococcus faecalis, and Lactobacillus casei [PMID:36015120].
Safety & adverse effects
The extract did not cause acute or chronic toxicity in mice [PMID:39403726]. An LD(50) of 5000 mg/kg indicates low toxicity [PMID:15120441]. Subchronic administration of aqueous extracts in mice showed no significant differences in serum transaminases, though some differences in micronucleus frequency were noted at 60 mg/kg freeze-dried extract [PMID:35544844].
Evidence summary
The current evidence is primarily based on preclinical in vitro and in vivo animal studies (Level D) and literature reviews (Level C), with no human clinical trials provided.
PubMed sources
1.PMID: 35153134 (2022) — Peperomia pellucida (L.) Kunth and eye diseases: A review on phytochemistry, pharmacology and toxicology. · Journal of integrative medicine
2.PMID: 30562552 (2019) — The chemistry and biological activities of Peperomia pellucida (Piperaceae): A critical review. · Journal of ethnopharmacology
3.PMID: 40630672 (2025) — Peperomia Pellucida (L.) Kunth: A Decade of Ethnopharmacological, Phytochemical, and Pharmacological Insights (2014-2025). · Journal of experimental pharmacology
4.PMID: 39403726 (2024) — Peperomia pellucida's Ingredients, Antioxidant Properties, and Safe Usage as Food and Herbal Medicine. · Journal of microbiology and biotechnology
5.PMID: 35467241 (2022) — Gastroprotective activities of Peperomia pellucida L. and Pachyrhizus erosus L. extracts combination on ethanol-induced rats.
Government sources
No direct government monograph is available for this herb. The content below is AI-generated and has not been verified against an authoritative government source. Use the search links to check official sources before relying on this information.
6.PMID: 37950747 (2024) — Carotane sesquiterpenes from Peperomia pellucida and their anti-infective activities. · Natural product research
7.PMID: 39539670 (2024) — Anti-inflammatory effectiveness of Peperomia pellucida (L.) Kunth in rats induced with periodontitis. · Biochemistry and biophysics reports
8.PMID: 33828573 (2021) — Biosynthesis of Pellucidin A in Peperomia pellucida (L.) HBK. · Frontiers in plant science
9.PMID: 39741574 (2024) — Cardioprotective Effect of Peperomia pellucida against Doxorubicin-Induced Cardiotoxicity in Wistar Rats via Modulation of Electrocardiographic and Cardiac Biomarkers. · Journal of pharmacopuncture
10.PMID: 39037823 (2024) — Peperomia pellucida (L.) Kunth suppresses glycation-induced inflammatory response in human retinal pigment epithelial cell line ARPE-19 via JAK-STAT3 signaling. · Archiv der Pharmazie
11.PMID: 35335210 (2022) — Chemical Composition of Leaves, Stem, and Roots of Peperomia pellucida (L.) Kunth. · Molecules (Basel, Switzerland)
12.PMID: 16499324 (2006) — Bioactive compounds from Peperomia pellucida. · Journal of natural products
13.PMID: 34759740 (2021) — Peperomia pellucida (L.) Kunth as an angiotensin-converting enzyme inhibitor in two-kidney, one-clip Goldblatt hypertensive rats. · Saudi journal of biological sciences
14.PMID: 33280962 (2021) — Peperomia pellucida (L.) Kunth herbal tea: Effect of fermentation and drying methods on the consumer acceptance, antioxidant and anti-inflammatory activities. · Food chemistry
15.PMID: 27169181 (2016) — A Review of Traditional Medicinal Plants from Kachin State, Northern Myanmar. · Natural product communications
16.PMID: 28372562 (2017) — Aqueous extract of Peperomia pellucida (L.) HBK accelerates fracture healing in Wistar rats. · BMC complementary and alternative medicine
17.PMID: 35544844 (2022) — Hepatotoxicity and Mutagenicity assessment during chronic in vivo exposure to aqueous extracts from Peperomia pellucida. · Anais da Academia Brasileira de Ciencias
18.PMID: 35061852 (2022) — Variation in Peperomia pellucida growth and secondary metabolism after rhizobacteria inoculation. · PloS one
19.PMID: 36237510 (2022) — Stable and reproducible expression of bacterial ipt gene under the control of SAM-specific promoter (pKNOX1) with interference of developmental patterns in transgenic Peperomia pellucida plants. · Frontiers in plant science
20.PMID: 39561439 (2024) — In vitro anti-inflammatory activity and molecular docking of Peperomia pellucida (L.) Kunth extract via the NF-κB and PPAR-γ signalling in human retinal pigment epithelial cells. · Bioorganic chemistry
21.PMID: 40156794 (2024) — Anti-arthritis Activity of Methanol Extract of Peperomia pellucida in Complete Freund's Adjuvant Induced Arthritis in Wistar Rats. · Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria
22.PMID: 34642085 (2021) — Angiotensin-converting enzyme inhibitors from plants: A review of their diversity, modes of action, prospects, and concerns in the management of diabetes-centric complications. · Journal of integrative medicine
23.PMID: 33114252 (2020) — Isolation and Characterization of Phenylpropanoid and Lignan Compounds from Peperomia pellucida [L.] Kunth with Estrogenic Activities. · Molecules (Basel, Switzerland)
24.PMID: 33813721 (2021) — Obtainment of the spray-dried extracts of Peperomia pellucida L. (H.B.K.) using different atomization temperatures: physicochemical characterization and technological development for pharmaceutical applications. · Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences
25.PMID: 41788793 (2026) — Formulation and in vitro evaluation of an anti-inflammatory herbal suppository containing Peperomia pellucida. · Frontiers in pharmacology
26.PMID: 23578859 (2013) — Ethanol extract of Peperomia pellucida (Piperaceae) promotes fracture healing by an anabolic effect on osteoblasts. · Journal of ethnopharmacology
27.PMID: 36015120 (2022) — Anticariogenic Activity of Three Essential Oils from Brazilian Piperaceae. · Pharmaceuticals (Basel, Switzerland)
28.PMID: 15120441 (2004) — Anti-inflammatory and analgesic activity of Peperomia pellucida (L.) HBK (Piperaceae). · Journal of ethnopharmacology